✦ LIBER ✦

DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancer

✍ Scribed by Kathrin Mutze; Rupert Langer; Felix Schumacher; Karen Becker; Katja Ott; Alexander Novotny; Alexander Hapfelmeier; Heinz Höfler; Gisela Keller

Book ID: 116430698
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 666 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.02.024

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

RAD51 as a potential biomarker and thera

RAD51 as a potential biomarker and therapeutic target for pancreatic cancer

✍ Nagaraj S. Nagathihalli; Ganesh Nagaraju 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 366 KB

Potential for the embryonic morphogen No

Potential for the embryonic morphogen Nodal as a prognostic and predictive biomarker in breast cancer

✍ Luigi Strizzi, Katharine M Hardy, Naira V Margaryan, David W Hillman, Elisabeth 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 980 KB

Fibroblast growth factor receptor 1 onco

Fibroblast growth factor receptor 1 oncogene partner as a novel prognostic biomarker and therapeutic target for lung cancer

✍ Yuria Mano; Koji Takahashi; Nobuhisa Ishikawa; Atsushi Takano; Wataru Yasui; Kou 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 688 KB

CD133/prominin-1 is a potential therapeu

CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers

✍ Smith, L M; Nesterova, A; Ryan, M C; Duniho, S; Jonas, M; Anderson, M; Zabinski, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 422 KB

A KRAS variant is a biomarker of poor ou

A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer

✍ Ratner, E S; Keane, F K; Lindner, R; Tassi, R A; Paranjape, T; Glasgow, M; Nallu 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 758 KB

Checkpoint Controls and Targets in Cance

Checkpoint Controls and Targets in Cancer Therapy Volume 2 || p27Kip1 as a Biomarker and Target for Treatment of Cancer

✍ Siddik, Zahid H. 📂 Article 📅 2009 🏛 Humana Press 🌐 English ⚖ 717 KB

Much work over the last two decades has firmly established that loss of cell cycle checkpoint regulation, and resultant unabated cellular proliferation, is an inherent characteristic of cancer. This loss may occur through aberration in any single component involved in signal transduction pathways th